The latest funding comes on top of $61.3 million in new funding the local biotech raised in April.
Image: Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville. COURTESY IMMUNOMIC THERAPEUTICS
{iframe}https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/washington/news/2021/01/15/immunomic-therapeutics-raises-16m-for-oncology.amp.html{/iframe}